Stockscreener 앱 받기
110.56
0.66%
-0.74
시간 외 거래:
111.00
0.44
+0.40%
전일 마감가:
$111.30
열려 있는:
$110.93
하루 거래량:
1.03M
Relative Volume:
0.49
시가총액:
$23.58B
수익:
$7.41B
순이익/손실:
$2.14B
주가수익비율:
11.85
EPS:
9.33
순현금흐름:
$2.70B
1주 성능:
-3.03%
1개월 성능:
-4.75%
6개월 성능:
+17.92%
1년 성능:
+1.38%
1일 변동 폭
$109.76
$111.47
1주일 범위
$109.73
$115.01
52주 변동 폭
$85.22
$122.00
티 로우 프라이스 Stock (TROW) Company Profile
명칭
T Rowe Price Group Inc
전화
(410) 345-2000
주소
HARBOR POINT, BALTIMORE, MD
Compare TROW vs BLK, BX, BN, BAM, APO
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TROW
T Rowe Price Group Inc
|
110.56 | 23.77B | 7.41B | 2.14B | 2.70B | 9.33 |
BLK
Blackrock Inc
|
1,173.73 | 179.79B | 27.61B | 7.13B | 3.76B | 40.76 |
BX
Blackstone Inc
|
143.93 | 109.90B | 16.59B | 6.83B | 869.79M | 4.4576 |
BN
Brookfield Corp
|
43.85 | 109.54B | 77.61B | 4.06B | -8.36B | 0.497 |
BAM
Brookfield Asset Management Ltd
|
54.31 | 87.05B | 5.07B | 2.48B | 2.37B | 1.5532 |
APO
Apollo Global Management Inc
|
140.76 | 81.86B | 31.69B | 2.94B | 8.43B | 1.5206 |
티 로우 프라이스 Stock (TROW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 개시 | BMO Capital Markets | Market Perform |
| 2024-09-12 | 개시 | Wells Fargo | Equal Weight |
| 2024-08-27 | 개시 | Barclays | Underweight |
| 2024-04-11 | 업그레이드 | Keefe Bruyette | Underperform → Mkt Perform |
| 2024-04-08 | 업그레이드 | TD Cowen | Sell → Hold |
| 2024-01-08 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-01-04 | 개시 | TD Cowen | Underperform |
| 2023-10-31 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-05-19 | 개시 | Citigroup | Sell |
| 2022-12-15 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-19 | 개시 | Credit Suisse | Underperform |
| 2022-07-11 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-06-29 | 다운그레이드 | Keefe Bruyette | Mkt Perform → Underperform |
| 2022-06-13 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-04-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-12 | 재확인 | Citigroup | Sell |
| 2022-01-04 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-12-17 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-12-16 | 재개 | BofA Securities | Underperform |
| 2021-10-22 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-04-14 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2021-03-30 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2021-01-05 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-11-19 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-03-24 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2019-10-08 | 개시 | BMO Capital Markets | Market Perform |
| 2019-03-08 | 재확인 | BofA/Merrill | Buy |
| 2019-01-31 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-01-04 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-12-06 | 재확인 | BofA/Merrill | Buy |
| 2018-10-26 | 재확인 | Barclays | Underweight |
| 2018-09-07 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2018-05-16 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-01-09 | 업그레이드 | UBS | Sell → Neutral |
| 2018-01-08 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-10-27 | 재확인 | Barclays | Underweight |
| 2017-10-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2017-09-28 | 업그레이드 | Goldman | Neutral → Buy |
| 2017-09-08 | 개시 | Barclays | Underweight |
| 2017-05-24 | 다운그레이드 | UBS | Buy → Sell |
| 2017-04-26 | 다운그레이드 | Argus | Buy → Hold |
| 2017-03-17 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
모두보기
티 로우 프라이스 주식(TROW)의 최신 뉴스
T. Rowe Price (TROW) Q2 2026 Earnings Call Transcript - AOL.com
T. Rowe Price Group (NASDAQ:TROW) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
D.A. Davidson & CO. Has $6.46 Million Stake in T. Rowe Price Group, Inc. $TROW - MarketBeat
T. Rowe Price (TROW) Reworks Leadership To Speed AI Push And Back Crypto - Yahoo Finance
TROW|T Rowe Price Group Inc|Price:110.560|Chg%:-0.740 - TradingKey
T. Rowe Price Associates (THG) discloses 5.2% Hanover Insurance ownership stake - Stock Titan
T. Rowe Price (MLTX holder) discloses 5.3% MoonLake Immunotherapeutics position - Stock Titan
T. Rowe Price Investment Management (PRAA) discloses 7.9% PRA Group ownership - Stock Titan
T. Rowe Price (VICR) discloses 7.0% beneficial stake in Vicor common stock - Stock Titan
T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock - Stock Titan
T. Rowe Price Investment Management (PCTY) discloses 5.8% Paylocity ownership in 13G/A - Stock Titan
T. Rowe Price (SVV) discloses 7.39M-share position in Savers Value Village - Stock Titan
T. Rowe Price Investment Management (AIZ) reports 4.9% Assurant stake in 13G/A - Stock Titan
T. Rowe Price Investment Management (MTSI) discloses 2.85M MACOM shares in 13G/A - Stock Titan
T. Rowe Price (UNIT) discloses 5.0% Uniti Group ownership in Schedule 13G/A - Stock Titan
T. Rowe Price Investment Management (GHM) discloses 5.2% Graham Corp ownership - stocktitan.net
T. Rowe Price Investment Management (USCB) discloses 8.6% ownership of USCB Financial - Stock Titan
T. Rowe Price Investment Management (GLNG) discloses 6.2% Golar LNG common stock holding - Stock Titan
T. Rowe Price Investment Management (TFX) discloses 7.2% ownership in Teleflex - stocktitan.net
T. Rowe Price Investment Management (MIAX) discloses 5.3% holding in Miami International - Stock Titan
T. Rowe Price Investment Management (STTK) reports 15.3% stake in Shattuck Labs - Stock Titan
T. Rowe Price Investment Management (MPTI) discloses 5.9% holding in M-TRON Industries - stocktitan.net
T. Rowe Price updates 6.5% Safehold Inc. (SAFE) ownership in Schedule 13G/A - Stock Titan
T. Rowe Price Investment Management (BELFA) discloses 4.4% Bel Fuse Inc-CL B holding - Stock Titan
T. Rowe Price Investment Management (NI) discloses 6.2% beneficial stake in NiSource - stocktitan.net
T. Rowe Price Investment Management (DCBG) discloses 7.2% Dime Community stake - Stock Titan
T. Rowe Price Investment Management (PTC) discloses 13.1M-share position in PTC Inc. - Stock Titan
T. Rowe Price Investment Management (EQBK) discloses 11.4% Equity Bancshares ownership - Stock Titan
Cabaletta Bio (CABA): T. Rowe Price reports 11.6% common stock stake - Stock Titan
T. Rowe Price (STVN) cuts Stevanato stake to 3,921 shares, 0.0% - Stock Titan
T. Rowe Price Associates (HXL) discloses 5.86M-share position in Hexcel - Stock Titan
T. Rowe Price (WOLF) discloses 6.1M Wolfspeed shares held for clients - Stock Titan
T. Rowe Price (MQ) discloses 11.6% Marqeta stake; Mid-Cap Value Fund holds 5.1% - Stock Titan
Skyward Specialty (SKWD): T. Rowe Price Associates reports 6% ownership stake - Stock Titan
T. Rowe Price Associates (NTRA) discloses 9.0M-share Natera stake in updated 13G - Stock Titan
T. Rowe Price Associates (SMA) reports 5.27M-share, 9.5% stake in SmartStop - Stock Titan
T. Rowe Price Associates (VRDN) discloses 5.2% Viridian Therapeutics ownership in 13G - Stock Titan
T. Rowe Price (CCC) discloses 7.5% beneficial stake in CCC Intelligent Solutions - stocktitan.net
T. Rowe Price Associates (MRX) discloses 6.8% Marex Group holding in 13G - Stock Titan
T. Rowe Price Associates (SARO) discloses 13.6% holding in StandardAero Inc. - Stock Titan
T. Rowe Price stakes 5.6% in Keysight Technologies (KEYS) common stock - Stock Titan
T. Rowe Price reports 9.8M Old Dominion Freight Line (ODFL) shares - Stock Titan
T. Rowe Price Associates (AAP) reports 14% stake in Advance Auto Parts common stock - Stock Titan
T. Rowe Price (PEB) discloses 8.58M-share Pebblebrook Hotel Trust stake in 13G/A - Stock Titan
T. Rowe Price Associates (IBP) discloses 4.3% holding in Installed Building Products - stocktitan.net
T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan
T. Rowe Price Associates (VRRM) reports 241,697 Verra Mobility shares in 13G/A - Stock Titan
T. Rowe Price (ARGX) discloses 2.68M argenx SE ADRs with 4.3% ownership - stocktitan.net
Cullinan Therapeutics (CGEM): T. Rowe Price reports 6.2% ownership stake - Stock Titan
T. Rowe Price Associates (KNF) reports 5.1M Knife River Corp shares, a 9% stake - Stock Titan
Shoals Technologies (SHLS): T. Rowe Price reports 12.9% ownership stake - Stock Titan
티 로우 프라이스 (TROW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.63%
0.49%
자본화:
|
볼륨(24시간):